Sectors
OKUR
OnKure Therapeutics, Inc.
4.05
11 x 3.64
1 x 4.40
bid
ask
-
0.01
0.32%
09:41 AM
timesize
| Ytd | 39.55% | |
| 1y | 99.36% |
3.98
day range
4.11
1.93
52 week range
5.38
| Open | 4.07 | Prev Close | 4.06 | Low | 3.98 | High | 4.11 | Mkt Cap | 54.56M |
| Vol | 3.31K | Avg Vol | 302.33K | EPS | -3.50 | P/E | -1.14 | Forward P/E | -2.64 |
| Beta | 0.29 | Short Ratio | 19.81 | Inst. Own | 53.88% | Dividend | N/A | Div Yield | N/A |
| Ex Div Date | N/A | Earning | 08-15 | 50-d Avg | 4.24 | 200-d Avg | 3.60 | 1yr Est | 34.75 |
OKUR News
benzinga.com
CORRECTION: OnKure Therapeutics Q2 EPS $(0.31) Beats $(0.54) Estimate
OnKure Therapeutics (NASDAQ:OKUR) reported quarterly losses of $(0.31) per share which beat the anal
globenewswire.com
OnKure Therapeutics Reports Second Quarter 2026 Financial Results and Provides Business Highlights
-- Executing IND-enabling activities for next-generation PI3Kα pan-mutant selective candidates OKI-
benzinga.com
HC Wainwright & Co. Maintains Buy on OnKure Therapeutics, Lowers Price Target to $21
HC Wainwright & Co. analyst Robert Burns maintains OnKure Therapeutics (NASDAQ:OKUR) with a B
benzinga.com
12 Health Care Stocks Moving In Friday's Pre-Market Session
benzinga.com
12 Health Care Stocks Moving In Thursday's After-Market Session